10:40 – 11:10

 

Case of late CMV and Resistance
Including Panel Discussion and Polling Questions
Per Ljungman, MD, PhD & Panel

11:10 – 11:40

 

Case of refractory CMV
Including Panel Discussion and Polling Questions
Johan Maertens, MD, PhD & Panel

FACULTY

Jan Styczynski, MD (Moderator)
Chairman, EBMT Infectious Diseases Working Party
Department of Pediatric Hematology and Oncology
Collegium Medicum
Nicolaus Copernicus University
Bydgoszcz, Poland

Per Ljungman, MD, PhD
Professor of Hematology
Karolinska University Hospital
Stockholm, Sweden

Johan Maertens, MD, PhD
Associate Professor of Hematology
University Hospitals Leuven
Leuven, Belgium

LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:

• Select anti-CMV therapy in HCT patients using evidence-based therapeutic approaches and knowledge of emerging therapies in clinical trials
• Manage CMV treatments in HCT patients based on viral load, side effect profile, and consideration of antiviral resistance
• Differentiate between CMV recurrence, resistance, or late recurrence and implement appropriate therapies
• Describe the burden of CMV infection in HCT patients, including the impact of CMV seropositivity and indirect effects

TARGET AUDIENCE
This educational activity is designed for practicing clinicians, including hematology and infectious disease specialist clinicians in the United States and Europe, who manage CMV infection and disease in HCT patients.

Disclosure of Conflicts of Interest
It is the policy of AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by RMEI and AKH prior to accreditation of the activity and may include any of, or a combination of, the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence supports the recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.

Provider Statement
This activity is jointly provided by RMEI Medical Education and Advancing Knowledge in Healthcare.

Commercial Support
This symposium is supported by an independent medical education grant from Takeda.

FEE INFORMATION
There is no fee for this educational activity however participants must be registered for the 46th EBMT Annual Meeting (EBMT 2020).

QUESTIONS?
Please contact Nicole Neely at nneely@rmei.com.

REGISTER

FOLLOW RMEI
   

Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.